Daan C.
- Country
- The Netherlands
- Department
- Hematology
Research Overview
- Phase 2/3 Randomized Open‑Label Study of MK‑1045 Versus Blinatumomab in Relapsed/Refractory CD19‑Positive B‑Cell Acute Lymphoblastic Leukemia
- Phase II Study of Pirtobrutinib with Epcoritamab Combination Therapy in Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
- Phase 2 Evaluation of Golcadomide (CC-99282) in Relapsed/Refractory Primary and Secondary Central Nervous System Large B-Cell Lymphoma
Data & Insights
Has run more than one trial at 5 of 43 partner sites.
Specializations
Hematologic Malignancies
Focuses on the diagnosis and treatment of blood‑derived cancers.
- Acute Myeloid Leukemia
- Chronic Lymphocytic Leukemia
- Multiple Myeloma
- Diffuse Large B‑Cell Lymphoma
- Mantle Cell Lymphoma
Investigations include novel targeted agents and combination regimens.
Solid Tumor Oncology
Explores therapeutic strategies for non‑small cell lung cancer and related malignancies.
- Metastatic Castration‑Resistant Prostate Cancer
- Advanced Pancreatic Ductal Adenocarcinoma
- Colorectal Liver Metastases
- Breast Cancer (HR+/HER2‑)
- Urothelial Carcinoma
Emphasis is placed on precision medicine and novel immunotherapies.
Cardiovascular and Thrombotic Disorders
Addresses acute and chronic conditions of the heart and vasculature.
- Acute Myocardial Infarction
- Acute Coronary Syndrome
- Atrial Fibrillation
- Peripheral Arterial Disease
- Venous Thromboembolism
Research includes antiplatelet strategies and anticoagulation optimization.
Pulmonary Fibrosis and Interstitial Lung Disease
Targets progressive scarring and inflammation of the lung parenchyma.
- Idiopathic Pulmonary Fibrosis
- Progressive Pulmonary Fibrosis
- Pulmonary Sarcoidosis
- Chronic Thromboembolic Pulmonary Hypertension
- Fibrotic Lung Disease
Efforts focus on antifibrotic agents and disease‑modifying therapies.
Renal and Metabolic Disorders
Investigates kidney disease and metabolic risk factors.
- Chronic Kidney Disease Stage 5
- Hypertension
- Obesity
- Diabetes‑Related Vascular Complications
- Iron Deficiency Anemia
Studies evaluate cardiovascular outcomes and therapeutic safety in renal impairment.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.